The chart below shows how AMN performed 10 days before and after its earnings report, based on data from the past quarters. Typically, AMN sees a +1.49% change in stock price 10 days leading up to the earnings, and a -8.10% change 10 days following the report. On the earnings day itself, the stock moves by -0.04%. This data can give you a slight idea of what to expect for the next quarter's release.
Positive
Revenue Exceeds Guidance: Revenue of $688 million was above the high-end of guidance.
EBITDA Exceeds Analyst Estimates: Adjusted EBITDA of $74 million was above the consensus of sell-side analyst estimates.
Q3 Revenue Performance: Nurse and Allied Solutions reported $399 million in revenue in the third quarter, 4% better than consensus due primarily to several beneficial factors that increased revenue by approximately 2%.
Market Stabilization Signs: We continue to see signs of a stabilizing market with increasing demand for travel nurse staffing and healthy demand in most other staffing markets.
Stable Clinician Bill Rates: We have also seen relatively stable bill rates for clinicians placed across our nurse, allied and locums businesses.
Negative
Revenue Decline Analysis: Revenue decreased by 19% from the third quarter of 2023 and down 7% sequentially, primarily due to lower volume in nurse and allied interim and search businesses.
Gross Margin Decline: Consolidated gross margin for the third quarter was 31%, a decrease of 290 basis points year-over-year, driven by lower-margin across all three segments.
EBITDA Decline Analysis: Third quarter adjusted EBITDA was $74 million, a decrease of 45% year-over-year and 21% sequentially.
Net Income Decline: Third quarter net income was $7 million, down 87% year-over-year and 57% sequentially.
Earnings Per Share Decline: Third quarter GAAP-diluted earnings per share was $0.18, compared to $1.97 in the prior year period and $0.98 in the prior quarter.
AMN Healthcare Services, Inc. (AMN) Q3 2024 Earnings Call Transcript
AMN.N
-4.7%